Clinical Trial Update: Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects [Phase 1]

View source ↗

Summary

A Phase 1 trial testing whether adding naltrexone to olanzapine (Zyprexa) can reduce metabolic side effects in people with schizophrenia or psychotic disorders …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Naltrexone (Naltrexone)
• Zyprexa (olanzapine)

Snippet

Sponsor: Mclean Hospital | Conditions: Schizophrenia, Psychotic Disorders | Phase 1 | Status: COMPLETED